News

Aquaporin A/S Announces Final Day for Shares Trading

Aquaporin A/S Announces Final Day for Shares Trading

Aquaporin A/S Announces Final Day for Shares Trading

Company Announcement
No. 01/2026

Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company Registration No.: DK28315694

Aquaporin A/S declares that today is the final day for trading shares that include pre-emptive subscription rights related to the upcoming rights issue. It is essential for investors to consider that shares traded after the designated time of 5:00 p.m. CET will no longer come with these rights. This means that any transactions occurring after this cutoff will exclude the ability to participate in the share subscription process.

Key Details About the Rights Issue

Trading Day Cutoff

The last cum-rights trading day is today. Following this, shares bought and sold will not carry the subscription rights necessary for the rights issue, commencing a new trading cycle.

Rights Allocation

For shareholders on record as of the specified date at 5:59 p.m. CET, ten pre-emptive rights will be allocated for each existing share held. These rights offer the opportunity to subscribe for new shares in the forthcoming rights issue.

Subscription Process and Rights Trading Period

Subscription Ratio Explained

The ratio for subscription in the rights issue is set at 10:3, meaning shareholders will need three pre-emptive rights to acquire one new share priced at DKK 1. This is a strategic move, designed to engage existing shareholders in the growth of the company.

Timeline for Rights Trading

The pre-emptive rights trading will commence on January 5, 2026, at 9:00 a.m. CET and will conclude on January 16, 2026, at 5:00 p.m. CET. It is critical for investors to make their trading decisions within this window to benefit from the rights issue.

Important Considerations

Implications of Not Exercising Rights

Investors should be aware that any pre-emptive rights not sold or actively used by the end of the subscription period will expire worthless. This underscores the importance of timely participation in the rights issue to maintain shareholding stakes.

Subscription Period for New Shares

The period during which shareholders can exercise their pre-emptive rights to subscribe for the new shares will start on January 7, 2026, and will close on January 20, 2026, at 5:00 p.m. CET. It is vital for current shareholders to act promptly to avoid missing out on this opportunity.

Potential Impact on Shareholders

Shareholders who choose not to exercise their full pro-rata rights may suffer a significant dilution of their ownership—up to 77%—if all new shares are fully subscribed. Thus, active participation is strongly encouraged to protect equity interests.

About Aquaporin A/S

Aquaporin A/S is at the forefront of innovation in water technology, operating from its headquarters in Denmark while also maintaining a global presence. The company focuses on water filtration solutions utilizing biotechnology to address pressing global water resources challenges.

Utilizing the pioneering Aquaporin Inside® technology, derived from Nobel Prize-winning research, Aquaporin produces membranes designed to enhance both industrial water treatment and drinking water quality. The reach of its solutions extends beyond borders, collaborating with partners worldwide to create effective water management strategies.

Frequently Asked Questions

What is the importance of the last day of trading?

The last day of trading is crucial as shares bought after this date will not include pre-emptive rights, affecting shareholders' ability to subscribe for new shares.

What is the subscription ratio in the rights issue?

The subscription ratio for the rights issue is 10:3, requiring three rights to obtain one new share.

When does the rights trading period commence?

The rights trading period begins on January 5, 2026, and ends on January 16, 2026.

What happens if rights are not used?

Any unused pre-emptive rights will expire and hold no value after the trading period ends.

How does dilution affect shareholders?

Shareholders who do not fully participate in the rights issue may face up to 77% dilution of their shares, significantly affecting their ownership stake.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Greenberg Traurig Shines in 2027 Latin Lawyer 250

Updated Category News Views 10

Greenberg Traurig's Noteworthy Recognition Amid the cacophony of the legal world, there's a name that's making increasingly undeniable waves in the Latin American market: Greenberg Traurig. The 2027 edition of the Latin Lawyer 250 just dropped, and Greenberg Traurig isn't merely included—it's recognized across an impressive 11 practices with 24 attorneys lauded for...

Continue Reading
HDFC Bank Faces Fraud Allegations Amidst Stock Drop

Updated Category News Views 11

Securities Fraud Rocks HDFC Bank It seems HDFC Bank's latest saga could be the kind of mess that leaves investors clutching their balance sheets. And with the class action lawsuit hanging over their heads, a lot of folks will want to grab their lawyers faster than a trader snags a bagel at the opening bell. HDFC Bank's stock has taken a punch in the gut, falling...

Continue Reading
iScreen's Digital Pets Revamp iPhone Customization Game

Updated Category News Views 5

Digital Companions Shake Up iPhone Screens Walking into the mobile app space like a bold artist striding onto a blank canvas, iScreen is shaking up the phone customization scene with its new interactive digital pet experience. This is no ordinary update, folks. If you've ever felt your iPhone home screen was lacking a bit of pizzazz—you're in luck. With iScreen's latest...

Continue Reading
Aevex Lawsuit Deadline: Investor Repercussions

Updated Category News Views 9

A Tangle of Allegations and IPO Woes So, Aevex Corp finds itself tangled up in legal webs after accusations of sneaky shenanigans around its IPO hit the courts. You’ve got a class action lawsuit brewing, and it uses some spicy language about premature stock selling—sure turns up the heat. We’re talking about a tight window for investors; October 20, 2026 is your...

Continue Reading
YFORE's ODMS: A Leap in Vehicle Cabin Safety

Updated Category News Views 11

A New Era for In-Cabin Monitoring There's a fresh scent in the Suwanee air, and it's coming from YFORE Technology's newly minted North American manufacturing digs in Georgia. You'd think it's just another plant popping up, right? But here's where things get spicy—YFORE has rolled out the Occupant & Driver Monitoring System (ODMS). This isn't your vanilla monitoring...

Continue Reading
Aardvark Therapeutics Faces Securities Fraud Lawsuit

Updated Category News Views 16

Investors Gear Up for Legal Battle There's nothing quite like the sound of a gavel about to drop when a company gets tangled up in a securities fraud lawsuit. This time, Aardvark Therapeutics, Inc. is in the hot seat. Shareholders are ruffling their feathers, and they're ready to take the company to court over claims of misleading information. You know the drill: someone...

Continue Reading
Armor Health Elevates Client Relations Focus with New VP

Updated Category News Views 5

Strengthening Ties in a Rapidly Expanding Sector What's the buzz in the correctional healthcare circuit? Armor Health's latest move is making waves. They've carved out a new high-level spot for an old hand, Tamara Taylor, tasking her with sharpening their client partnerships. Now, any seasoned investor knows that building key relationships can make or break a business,...

Continue Reading
Art Residency Sparks Creative Fusion at The AGB

Updated Category News Views 15

The Museum's New Artistic Venture Add another name to the buzzworthy spaces: the Ashley Gibson Barnett Museum of Art just kicked off their Artist-in-Residence Program, featuring acclaimed talent Reynier Llanes. Running from September through November 2026, this initiative isn’t just about making room for an artist, it’s about offering a stage for creativity to thrive....

Continue Reading
Independent Group's $10M Funding Boosts New Politics

Updated Category News Views 18

Breaking the Chains of Political Gridlock We're living in times where political gridlock seems more certain than a bear market. But the Independent Leadership Council (ILC) is plowing through the stubborn terrain with a bulldozer of $10 million in funding. This was announced in D.C., and it's just the proof they need to try shaking up the duopoly defining American...

Continue Reading
NATURE Trial Success: enVast Cuts STEMI Infarct Size

Updated Category News Views 12

A New Angle on STEMI Treatment Who would've thought? In the crowded world of cardiovascular treatments, Vesalio just threw their hat into the ring with the enVast Coronary Clot Retriever. This gizmo's making waves after the NATURE trial results came down the pipeline. Dubbed a game-changer, it's shaking up how we tackle hefty thrombus burdens in STEMI patients. If you're...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Elegance of Toll Brothers' New Community Launch

Updated Category News Views 142

Exciting New Luxury Community by Toll Brothers We’re thrilled to announce the opening of Camas Meadows Crossing, a remarkable luxury townhome community by Toll Brothers, Inc. (NYSE:TOL). This new community, located in the Portland area, represents the company's first luxury townhome offering in this vibrant region, and it’s now open for sale. Camas Meadows Crossing: A...

Continue Reading
Woolpert Strengthens Global Presence with Bluesky Acquisition

Updated Category News Views 226

Woolpert Expands Global Service Network Woolpert, a pioneering company in geospatial services, recently announced a significant enhancement to its operational capacity by acquiring Bluesky International, an esteemed aerial survey firm in the market. Bluesky International: A Valuable Addition This strategic acquisition adds over 100 skilled professionals in surveying and...

Continue Reading
PetMed Express, Inc.: Insights on Q4 and FY 2025 Results

Updated Category News Views 154

PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) has provided an important update concerning its fourth quarter and fiscal year 2025 results alongside its Form 10-K filing. Details on Filing Challenges Recently, the Company filed a Form...

Continue Reading
Agnico Eagle Launches Competitive Bid for O3 Mining Shares

Updated Category News Views 103

Agnico Eagle Mines Limited's Bold Move Agnico Eagle Mines Limited (NYSE: AEM) is making waves in the mining sector with its ambitious offer to acquire O3 Mining Inc. (OTCQX: OIIIF). The company has proposed an all-cash bid of $1.67 per common share, a striking 58% premium over O3 Mining's recent trading price. This move underscores Agnico Eagle's commitment to...

Continue Reading
Saab's 2024 Results: Achieving Enhanced Growth and Innovation

Updated Category News Views 672

Saab's Year-End Overview for 2024 Saab has made remarkable strides in 2024, showcasing resilience and adaptability in a challenging global landscape. The company ended the year on a high note, exceeding expectations with strong organic sales growth and significant operational enhancements. Saab's management is optimistic, with a commitment to innovation and customer...

Continue Reading